Butadiene-induced intrastrand DNA cross-links: a possible role in deletion mutagenesis.
To initiate studies designed to identify the mutagenic spectrum associated with butadiene diepoxide-induced N(2)-N(2) guanine intrastrand cross-links, site specifically adducted oligodeoxynucleotides were synthesized in which the adducted bases were centrally located within the context of the human ras 12 codon. The two stereospecifically modified DNAs and the corresponding unmodified DNA were ligated into a single-stranded M13mp7L2 vector and transfected into Escherichia coli. Both stereoisomeric forms (R, R and S,S) of the DNA cross-links resulted in very severely decreased plaque-forming ability, along with an increased mutagenic frequency for both single base substitutions and deletions compared with unadducted DNAs, with the S,S stereoisomer being the most mutagenic. Consistent with decreased plaque formation, in vitro replication of DNA templates containing the cross-links by the three major E. coli polymerases revealed replication blockage by both stereoisomeric forms of the cross-links. The same DNAs that were used for replication studies were also assembled into duplex DNAs and tested as substrates for the initiation of nucleotide excision repair by the E. coli UvrABC complex. UvrABC incised linear substrates containing these intrastrand cross-links with low efficiency, suggesting that these lesions may be inefficiently repaired by the nucleotide excision repair system.
Carmical
J R
JR
Department of Preventive Medicine and Community Health, the Sealy Center for Molecular Science, The University of Texas Medical Branch, Galveston, Texas 77555, USA.
Kowalczyk
A
A
Zou
Y
Y
Van Houten
B
B
Nechev
L V
LV
Harris
C M
CM
Harris
T M
TM
Lloyd
R S
RS
D000251:Adenosine Triphosphatases / Q000378:metabolism; D001426:Bacterial Proteins / Q000378:metabolism; D001483:Base Sequence; D002070:Butadienes / Q000737:chemistry / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D003432:Cross-Linking Reagents / Q000737:chemistry / Q000494:pharmacology*; D004247:DNA / Q000737:chemistry / Q000187:drug effects*; D018736:DNA Adducts / Q000378:metabolism; D018076:DNA, Complementary / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism; D004852:Epoxy Compounds / Q000737:chemistry / Q000494:pharmacology*; D004926:Escherichia coli / Q000378:metabolism; D029968:Escherichia coli Proteins; D017353:Gene Deletion; D011905:Genes, ras / Q000235:genetics; D006147:Guanine / Q000378:metabolism*; D006801:Humans; D008969:Molecular Sequence Data; D016296:Mutagenesis; D009153:Mutagens / Q000737:chemistry / Q000494:pharmacology; D009693:Nucleic Acid Hybridization; D009841:Oligonucleotides / Q000494:pharmacology; D013237:Stereoisomerism
D001426:Bacterial Proteins; D002070:Butadienes; D003432:Cross-Linking Reagents; D018736:DNA Adducts; D018076:DNA, Complementary; D004268:DNA-Binding Proteins; D004852:Epoxy Compounds; D029968:Escherichia coli Proteins; D009153:Mutagens; D009841:Oligonucleotides; D006147:Guanine; C007366:diepoxybutane; D004247:DNA; C068631:UvrA protein, E coli; D000251:Adenosine Triphosphatases; C031763:1,3-butadiene